chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 1-2 minutes after vaccinations patient became nauseated and vomited small amounts clear water several times, and complained of ringing in ears and reported he was losing vision. Pt remained alert and oriented, skin was warm and dry, stayed seated in chair under observation of nurse, and was given a cool wet paper towel to place on forehead. Nausea resolved after approximately 5 minutes, patient began to feel better but ringing in ears and darkened vision  lasted another 2-3 min after nausea resolved, then patient reported he felt much better, vision and hearing were back to normal. There was no loss of consciousness. After 15 min patient ambulated and reported felt better, denied any further adverse symptoms. Continued to monitor for 10 min in lobby before patient was released with mother.
The day following my vaccination the site of injection was incredibly red, sore, hot to the touch, and very itchy. This inflammation and itchiness lasted for two weeks. When it finally subsided, I was left with a dark purple mark over a large patch of the area that looked like a bruise. The skin began to flake and peel over the next few days. It has now been over a month since vaccination, and I still have a purple mark over this area that does not appear to be going away.
Pt started getting a fever the night of the 16th. The patient vomited in the middle of the night. His fever persisted for 3 days.
He felt like he was getting COVID; strong reaction to both doses; He reported that he had bearable side effects; He had fever after 1st dose; He had chills; knocked me out/ bothered me; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (He felt like he was getting COVID), VACCINATION COMPLICATION (strong reaction to both doses), FEELING ABNORMAL (knocked me out/ bothered me), ADVERSE DRUG REACTION (He reported that he had bearable side effects) and PYREXIA (He had fever after 1st dose) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (he had COVID-19 infection last year and became quite ill) in 2020.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced FEELING ABNORMAL (knocked me out/ bothered me). On an unknown date, the patient experienced FEELING ABNORMAL (He felt like he was getting COVID), VACCINATION COMPLICATION (strong reaction to both doses), ADVERSE DRUG REACTION (He reported that he had bearable side effects), PYREXIA (He had fever after 1st dose) and CHILLS (He had chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (He felt like he was getting COVID), VACCINATION COMPLICATION (strong reaction to both doses), FEELING ABNORMAL (knocked me out/ bothered me), ADVERSE DRUG REACTION (He reported that he had bearable side effects), PYREXIA (He had fever after 1st dose) and CHILLS (He had chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications includes BP (blood pressure) medications (unspecified). Treatment medication includes anti-histamines (unspecified).   This case was linked to MOD-2021-324087 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Sep-2021: Significant Follow-up received on 20-Sep-2021 added new events and medical history
Heart arrhythmia, skipping beats every 10-20 beats. This was noticed the night I received the vaccine, but it may have started before the vaccine and be unrelated. But, after 3 days, the arrhythmia stopped, and my heart beat is back to normal, so my doctor says perhaps it WAS related to the vaccine.
SMALL HEADACHE; This spontaneous report received from a 62 year old male. The patient's height, and weight were not reported. The patient's past medical history included: thrombosis and failed back surgery and concurrent conditions included: thick varicose vein. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: unknown) dose was not reported, 1 total administered on 05-APR-2021 to left arm for prophylactic vaccination (dose number in series 1).  The patient experienced bleeding by ankle, bruising easy on arms, burning, dizziness, felt tired, leg pain, leg swelling, foot swelling, micro colitis, pain, sleepy, sore arm, swelling, thrombosis and burning went away, tightness in legs, calf muscle was so tight all the time, two bones fracture in right foot and warm bandana like headache when treated with covid-19 vaccine ad26. cov2. s for prophylactic vaccination (dose number in series 1).  The patient received booster of covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number: unknown and expiry: unknown) 1 total, dose was not reported, administered on NOV-2021 for prophylactic vaccination (dose number in series 2). The batch number was not reported and has been requested.  No concomitant medications were reported.  On an unspecified day in NOV-2021 a week before thanksgiving, the patient experienced small headache (Dose series number 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of small headache was not reported. This report was non-serious. This case, involving the same patient is linked to 20210436178 (dose number in series 1 case).
Covid-19; weakness; Cough; aches; lost smell; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19), ASTHENIA (weakness), COUGH (Cough), PAIN (aches) and ANOSMIA (lost smell) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ASTHENIA (weakness), COUGH (Cough), PAIN (aches) and ANOSMIA (lost smell). On 15-Jan-2021, the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19), ASTHENIA (weakness), COUGH (Cough), PAIN (aches) and ANOSMIA (lost smell) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, SARS-CoV-2 test positive: positive Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
This case was reported by a other health professional via sales rep and described the occurrence of injection site swelling in a female patient who received BEXSERO (batch number 151401, expiry date 30th December 2016). On 15th June 2016, the patient received the 1st dose of BEXSERO. On 17th June 2016, 2 days after receiving BEXSERO, the patient experienced injection site swelling, injection site induration and injection site warmth. On an unknown date, the outcome of the injection site swelling, injection site induration and injection site warmth were unknown. It was unknown if the reporter considered the injection site swelling, injection site induration and injection site warmth to be related to BEXSERO. Additional details were provided as follows: This case was reported by a medical assistant. The age at vaccination was not reported. The patient experienced swelling, hotness and induration (hardness) at the injection site. The sales representative called to report this adverse event and his call was solely to report the adverse event. The sales representative stated that, the healthcare professional did not need to be contacted, as she did not have any medical information questions.
Information has been received from a medical assistant student concerning another student in her class who was vaccinated with a dose of hep B virus vaccine rHBsAg (yeast). Subsequently, the pt developed anxiety, heart racing, panic attack, blurred vision, muscle weakness, numbness and tingling of the feet and arms, a watery mouth, shortness of breath, fatigue, irritability, chest pain, increased blood pressure, back ache, loss of appetite, mental fog and difficulty swallowing. No further information is available. Additional information has been requested. The reporter also noted that she had been vaccinated with a dose of hep B virus vaccine rHBsAg (yeast) and experienced the same symptoms and was diagnosed with anxiety (WAES 0403USA02341).
Arm was bruised & swollen. Patient had diarrhea & flu-like symptoms the next day. After getting immunizations he might have gotten frostbite from hunting.
On AM of 03/02/04 developed with left arm pain that radiated across back and to right arm and eventually down to toes.  She was seen in clinic on 03/02/04 and sent to ED for further testing.  She was seen in clinic on 03/03/04.  Sed rate ordered.  She was seen in clinic on 03/04/04: UA done.  Seen in clinic on 03/05/04 and also by MD on 03/05/04.  She was started on steroids by FMD.
No additional AE reported; Healthcare business professional states unspecified vaccines involved in an unspecified temperature excursion may have been administered to unknown patients/ were administered to multiple patients since they were invloved in a temperature excursion; This spontaneous report was received from a health care professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not provided.  On 04-OCT-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, route of administration defaulted to oral, lot number: W020106, expiration date was internally confirmed as 16-MAY-2023 (exact dose and dose number were not reported) and an improperly stored dose of diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) pre-filled syringe, lot number: U7205AA, expiration date was internally confirmed as 23-OCT-2024 (exact dose, dose number, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No additional adverse event (AE) details were provided (no adverse event).  On 26-SEP-2022, the administered doses of the suspect vaccines experienced a temperature excursion of the highest temperature of 9 degrees Celsius (C) for a total time of 15 minutes. It was unknown, whether the administered suspect vaccines experienced a previous temperature excursion. It was unknown, whether a digital data logger was involved.
Fever - Tmax 104.8 oral per parent; 101 rectal @ office fussy - resolved decreased appetite but taking bottles.
Dizziness.  BP 105/62, HR 88, RR 18.  Water given, rest, laid down.  Patient stable and released from the vaccination site.
This spontaneous report as received from a pharmacist refers to a 73 year old female patient. On 19-AUG-2013 the patient was vaccinated with a dose of ZOSTAVAX vial 19400 PFU, (lot #, expiration date, dose, route and indication unspecified). On an unknown date the patient had an injection site reaction after receiving ZOSTAVAX. The pharmacist stated that patient had severe swelling and redness that was approximately 12 inches in length, which started on approximately 20-AUG-2013 (one to two days after receiving ZOSTAVAX) and lasted for approximately one week. The patient sought medical attention via contact pharmacist. No treatment was given. The event outcome was reported as recovered in August 2013. Additional information has been requested.
Initial report received from a consumer, who is also the patient's mother, on 23 November 2009. A seven-week-old infant was exposed via breast milk to H1N1 (lot number UP012AA) when her mother received the vaccine on 16 November 2009. The patient had a history of lactose intolerance and cow protein intolerance. She was taking approximately 80% of her dietary intake from breast milk, and supplementing with Nutramigen. According to the patient's mother, on 17 November 2009, one day post-vaccination, the patient began experiencing pain, inconsolable crying, back arching, and pulling her knees up. She consumed only half of her normal intake, and had orange streaks in her stool. On 20 November 2009, the patient's mother stopped breast feeding, and by that evening the patient was doing better. Within 24 hours, no orange streaks were noted in the patient's stool. The patient was not on any concomitant medications; her mother was taking prenatal vitamins. Follow-up information was received on 02 February 2010 from a physician. The female baby was born vaginally at 37 weeks gestation and weighed 5 pounds 14 ounces and was 18 and 3/4 inches in length. The baby's Apgar was 8 at 1 minute and 9 at 5 minutes and she had no congenital anomalies. This reporter also noted that she had received seasonal influenza vaccine while pregnant; this is reported in case number 2009-05153. Follow-up information received from a physician on 02 February 2010, confirmed that the mother had received FLUARIX (lot number AFLUA468CA) and not a sanofi-pasteur product. The linked case number 2009-05153 will be deleted from the database.
04/17 08.30P Arm and shoulder stiff, swollen and inflamed. Very tender, unable to raise arm above waist level.Headache and temperature, shivers. 04/18 08.30A arm still as above, made appointment to see doctor. Treatment injection of Methylprednisolone Sodium Succ. 125MG/2ML inj recon soln 60mg im x 1 intramuscular and Diphenhydramine HCL 50 MG/ML inj soln 25 mg im x 1 intramuscular.  Observation for 2 hours.  Benadry 25 MG oral cap 1 tab po q 4-6hoursIbrufen 800 MG oral tab 1 tab po tid prn pain Propxyphene N-Acetaminophen 100 MG-650 MG tab 1 tab Q4-6H Prn pain. Ice applied to left arm and chest, elevate as much as possible.
Administration Error: we administered Dose 1 Moderna when in fact the patient, verified, was given the Janssen vaccine by another company on 3/11/21. Patient has 2 accounts with arrangement of last name spelling which may have been a factor in this error.
About 1.5 weeks after receiving my second shot, I experienced a racing heart for 2 or 3 weeks. It would last for maybe an hour before calming down on its own. The times that I experienced the racing heart were not when you would expect it. I  would be doing the dishes or making dinner or sleeping and it would wake me up. My heart felt like it was pounding.
This initial spontaneous report was received on 31-AUG-2017 from a lawyer regarding a case in litigation and refers to a male patient of unknown age. Medical history, concurrent conditions, and concomitant medications were not provided. On or about 09-JUN-2009, the patient was inoculated with ZOSTAVAX, administered by the physician at a health care facility as recommended for routine adult health maintenance and for the prevention of shingles (dose, route of administration, site of administration and lot #, were not provided). The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 05-NOV-2012, he was treated by the physician (same physician who administered the vaccine on or about 09-JUN-2009) for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. On or about 10-APR-2013, the male patient received subsequent treatment from the same physician for ongoing and worsening symptoms of active problematic herpes zoster. The male patient has been prescribed valacyclovir (VALTREX) for management of his painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, he has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was not resolved. The lawyer felt the events were related to ZOSTAVAX. Additional information has been requested.
Headache, Fever, NauseaVomiting, Chills, Fatigue, Injection site pain Narrative:
Information was received from a pharmacy student concerning a patient of unknown age and gender. No specific information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The pharmacy intern stated that on an unknown date in 2017 (reported as "recently"), the "patient potentially with unspecified immunocompromising condition leading to a planned transplantation" (unspecified), received a dose of VARIVAX (lot number, dosage, and route of administration not provided). The pharmacy intern stated that the patient did not experience any adverse effects. The transplant was still pending. No further information was provided. Additional information has been requested.
Vaccine expired on 12/19/2021, vaccine administered on 12/21/2021. No adverse event reported.
Seizure (non-febrile) during sleep of unknown duration. Post-ictal period lasted about 1.5 hours.
Information has been received from a registered medical assistant concerning a 7 month old patient of unknown gender. The patient's concurrent conditions, medical histories and concomitant medications were not reported. On 28-APR-2017, the patient was vaccinated with LIQUID PEDVAXHIB (lot number N000236, expiration date 24-OCT-2019), intramuscularly for prophylaxis during or after a temperature excursion occurred. The vaccine was exposed to a temperature excursion of 52 degrees Fahrenheit for 2 hours. A data logger involved. There was no previous temperature excursion. No adverse events were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected as all scheduled correspondence has been received.; Sender's Comments:  US-009507513-1704USA001797: US-009507513-1706USA004370: US-009507513-1706USA004380: US-009507513-1706USA004381: US-009507513-1706USA004382:
Fever, chills and blood pressure - 210/114. Took 2 Lorazepam .5MG for BP. BP took 3 hours to return to normal. Itching over entire body started at same time and lasted 2 1/2 days
Shingles. One before the shot and one after /Suspected vaccination failure; Shingles; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles before vaccination, and was worst).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient received the Shingles vaccine and had shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset and laboratory confirmation for shingles were not provided.
Rash- competent w/ past - MMR rash. Decreased WBC count 1.7, ANC700. Resolved within 1wk.
It was discovered today that patient received a Pfizer vaccine at outside clinic on 03/05/2021. She received a Moderna vaccine from facility on 03/18/2021.
Right arm / have been hurting severely; Shoulder have been hurting severely; She is unable to sleep on it (right arm); This case was reported by a consumer and described the occurrence of pain in arm in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th November 2020, the patient received the 1st dose of Shingrix (intramuscular). In November 2020, immediately after receiving Shingrix, the patient experienced pain in arm, shoulder pain and difficulty sleeping. On an unknown date, the outcome of the pain in arm, shoulder pain and difficulty sleeping were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, shoulder pain and difficulty sleeping to be related to Shingrix.  Additional details were reported as follows: This case was reported by patient herself. The patient stated that since receiving the vaccine, her right arm and shoulder had been hurting severely, to the point that she was unable to sleep on it. The reporter consented to follow-up.
I tested positive for covid 19 the day after receiving the vaccine and am having serve symptoms already.  Cough, fever 100.6, heart rate 110, serve headache, body aches,  diarrhea.
103' Fever, chills, cold sweats throughout 2 nights (9/5 and 9/6) after flu shot. Intense migraine/headache pain and pressure that caused confusion, blurry vision and dizziness from 9/5 to 9/9 (still recurring as of this post).
Patient called and states injection site has rash and swollen. Patient visited doctor and diagnosed staph infection.
Pediarix vaccine expired on 04/04/2022. Pediarix vaccine was given on 4/15/2022. Patient had no adverse reactions from expired vaccine.
This pt had a "spell", possibly a seizure. Child received Prevnar at 10:00 on 1/30/01. Around 17:00, suddenly became limp, while eating. Mom thinks he passed out for 1 minute. No abnormal movements. 2nd episode about 19:00, eyes rolled back, passed out for several minutes. Brought to ER, immediately. Regain consciousness but was dazed and lethargic X 2 hours. That night started low-grade fevers.